After Hours Summary: ALLO falls -37.2% on FDA decision to place hold on clinical trials; ACCD -6.7% falls on earnings; QDEL +7.9% higher on bullish guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: QDEL +7.9% (issues Q3 guidance well above consensus estimate), DS +0.7% (guides Q3 revs slightly below dual analyst estimate)
Companies trading higher in after hours in reaction to news: EFTR +23.4% (presents new positive data for zotatifin in animal models of triple-negative breast cancer), VXRT +10.6% (oral COVID-19 vaccine candidate shown to reduce airborne transmission of SARS-CoV-2 in an animal model), RPTX +4.8% (issues statement regarding inadvertent issuance of abstract), BW +2.8% (awarded ~$10 mln contract to install ash-handling equipment), AERI +1.7% (presents overview of retina product candidates), WSM +0.9% (increases minimum hourly wage to $15/hr), SNY +0.4% (MRTX announces collaboration with SNY to evaluate adagrasib with Sanofi's investigational SHP2 inhibitor), SGMS +0.2% (wins Vermont Lottery's 10-yr gaming systems technology contract), VMW +0.2% (authorizes a new stock repurchase program worth $2 bln), PSB +0.1% (names new CFO)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: ACCD -6.7%
Companies trading lower in after hours in reaction to news: ALLO -37.2% (FDA places hold on the company's AlloCAR T clinical trials), NKTX -4% (provides updates for NKX019 and NKX101 development programs), TMC -2.8% (stock offering), NXTC -2.2% (reports preclinical data for NC410), RKLY -1.6% (stock offering), ACHR -1% (stock offering), BGNE -0.6% (receives regulatory approval in Australia for BRUKINSA), GTLS -0.5% (names new CFO), THO -0.2% (increases dividend), PRMW -0.1% (acquires Get Fresh, a water distributor in Poland), COIN -0.1% (SEC approves ETF that tracks stocks with significant bitcoin exposure, according to Business Insider)